Home › Merck to Present New Data in Five Tumor Types from Studies Evaluating Pembrolizumab
 

Keywords :   


Merck to Present New Data in Five Tumor Types from Studies Evaluating Pembrolizumab

2014-09-03 05:50:17| Biotech - Topix.net

Merck , known as MSD outside the United States and Canada, today announced the presentation of data from ongoing clinical trials evaluating the anti-tumor activity of pembrolizumab, the company's investigational anti-PD-1 antibody, at the European Society of Medical Oncology 2014 in Madrid, Spain, September 26 - 30. Data on pembrolizumab are ... (more)

Tags: data present types studies

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
15.05Exploring the future of agriculture
15.05American, Mexican, and Canadian cattle producers sign joint statement
15.05Attitudes EWG Verified Skincare Line Oceanly Expands with SPF Offerings
15.05Sherwin-Williams Packaging Coatings Expands Non-BPA Coatings Production in Europe
15.05Voesh Unveils Body Refining Roller Crme Ahead of Summer 2024
15.05KANSAI HELIOS Completes Acquisition of WEILBURGER Coatings
15.05TSCRA Disaster Relief Fund distributes $900,000 in financial assistance
15.05Portugal\'s Etifam adds Screen Truepress Label 350UV SAI-E
More »